Sponsor hub

Medical College of Wisconsin clinical trial failures

Review 41 stopped clinical trials from Medical College of Wisconsin, including disease areas, phases, and classified stop reasons.

This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 2 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.

Total stopped trials41
Likely biological signals2
Shown below41

Dominant stop reasons

OPERATIONAL
27
OTHER/UNKNOWN
11
EFFICACY/FUTILITY
1
REGULATORY
1
SAFETY
1

Notable sponsors

Medical College of Wisconsin
41

Related phases

Phase I
15
Phase II
10
Phase IV
6
Unknown
5
Phase III
4

Crawlable stopped-trial records

Open Explore

Showing up to 41 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.

NCT05094206: CAR20.19.22 T-cells in Relapsed, Refractory B-cell Malignancies

Phase I B-cell Non Hodgkin Lymphoma trial by Medical College of Wisconsin. Stop reason: REGULATORY.

Treated four patients: 2 at a dose of 1x10\^6 cells/kg and 2 ad at dose of 2.5x10\^6 cells/kg. All four patients had no in-vivo expansion and no meaningful response to therapy. At this point per FDA guidance we will not be treating more patients.